Precision System Science Co., Ltd. Reports Consolidated Earnings Results for the First Quarter Ended September 30, 2015; Provides Earnings Guidance for the Six Months Ending December 31, 2015 and for the Fiscal Year Ending June 30, 2016, 2017 and 2018
November 12, 2015
Share
Precision System Science Co., Ltd. reported consolidated earnings results for the first quarter ended September 30, 2015. For the quarter, net sales were JPY 1,054 million against JPY 1,104 million a year ago. Operating loss was JPY 153 million against JPY 193 million a year ago. Ordinary loss was JPY 178 million against JPY 156 million a year ago. Net loss attributable to parent company shareholders was JPY 182 million or JPY 9.82 per share against JPY 163 million or JPY 8.94 per share a year ago. Loss before income taxes and others was JPY 178.339 million against JPY 160.741 million a year ago.
For the six months ending December 31, 2015, the company expects sales of JPY 2,600 million, operating loss of JPY 70 million, ordinary loss of JPY 100 million and net loss attributable to parent company shareholders of JPY 115 million or JPY 5.85 per share.
For the fiscal year ending June 30, 2016, the company expects sales of JPY 5,790 million, operating income of JPY 100 million, ordinary income of JPY 60 million and net income attributable to parent company shareholders of JPY 25 million or JPY 1.24 per share.
For the fiscal year of 2017, the company expects sales of JPY 6,730 million, operating income of JPY 510 million, ordinary income of JPY 495 million and net income attributable to parent company shareholders of JPY 410 million.
For the fiscal year of 2018, the company expects sales of JPY 7,920 million, operating income of JPY 910 million, ordinary income of JPY 895 million and net income attributable to parent company shareholders of JPY 720 million.
Precision System Science Co., Ltd. is engaged in the development, manufacture and sales of various devices for lab (laboratory) automation and clinical diagnosis. The equipment business provides various automated equipment for lab such as deoxyribonucleic acid (DNA) automatic extractors and others, immunochemical luminescence measuring devices, specimen pretreatment devices for clinical diagnosis, and fully automated gene diagnostic equipment, among others. The reagents and consumables business provide various reagents used for DNA extraction and protein purification, as well as dedicated plastic consumables such as reaction vessel and others. The maintenance-related segment is engaged in equipment maintenance business, and the sales of spare parts (replacement parts). The contract manufacturing business is engaged in the contract manufacturing business.
Precision System Science Co., Ltd. Reports Consolidated Earnings Results for the First Quarter Ended September 30, 2015; Provides Earnings Guidance for the Six Months Ending December 31, 2015 and for the Fiscal Year Ending June 30, 2016, 2017 and 2018